Frequently Asked Questions. Neuraxial Connectors (ISO ) October 19, 2016 (v2)

Size: px
Start display at page:

Download "Frequently Asked Questions. Neuraxial Connectors (ISO ) October 19, 2016 (v2)"

Transcription

1 Frequently Asked Questions Neuraxial Connectors (ISO ) October 19, 2016 (v2) 1

2 Frequently Asked Questions Neuraxial Connectors (ISO ) 1. What is a small-bore connector? 2. What changes are coming to small-bore connectors? 3. Will new neuraxial medical connectors have distinct names? 4. Why is industry adopting the new ISO neuraxial connector? 5. What are the implications of these new standards? 6. What connectors are affected by the ISO (NRFit) connector standard? 7. Which devices are affected by the ISO standard? 8. Who developed the proposed new ISO connector design? 9. Why should we adopt the new connector? 10. What makes the new ISO connector different from the current Luer system? 11. When will the new ISO connector be available? 12. How will the new ISO connector be introduced into my healthcare organization? 13. If we use Neuraxial parts from another manufacturer s set, how will we know the products will work together? 14. Is it mandatory to transition to the new ISO connector? 15. When will the neuraxial devices with current connectors be discontinued? 16. Will there be new item numbers or SKUs for the new sets? 17. If applicable, when will the new item numbers be available and how will we know when to order the new item numbers (SKUs)? 18. Will there be a price increase? 19. Will there be a standard color for the connector? 20. What is the role of StayConnected? 21. Does this new system require that devices using the Luer connector become obsolete? 22. Will there be adapters for different kinds of syringes? 2

3 1. What is a small-bore connector? A small-bore connector is a connector with an inner diameter of less than 8.5mm used to connect medical devices, components and accessories for the purposes of delivering fluids or gases. 2. What changes are coming to small-bore connectors? The International Organization for Standardization (ISO 1 ) has developed a series of standards for small-bore connectors, known as ISO series. These standards will provide design and performance specifications for a range of connectors which can be used for different medical device applications ( enteral ENFit, neuraxial and major regional NRFit, intravascular and hypodermic Luer, etc.) and which will reduce the risks of misconnections between applications section Use Common name -2 Breathing systems and driving gases -3 Enteral applications ENFit -4 Urethral and urinary applications -5 Limb cuff inflation -6 Neuraxial applications and major NRFit regional anesthesia -7 intravascular or hypodermic applications Luer 3. Will new neuraxial medical connectors have distinct names? Connector naming is not included in the ISO series of standards. Therefore, companies are free to name the new connectors as they choose. GEDSA and members of the ISO joint working group have proposed the use of the name NRFit (pronounced ner-fit ) for the new connectors used for neuraxial and major regional applications. NRFit is a name that will be used to identify devices that comply with the ISO standard. 4. Why is industry adopting the new ISO neuraxial connector? The standard small-bore connector in the medical device field for many years has been the Luer connector. Because the Luer connector was such an effective and reliable design, it has been used in many different types of device applications, such as vascular, enteral, respiratory, epidural, and intrathecal. The consequence of this has been misconnection with devices that were not meant to connect, such as the delivery of toxic chemotherapy drugs into the spinal canal. As well as preventing the delivery of IV drugs into the neuraxial space, use of the ISO connectors will also prevent wrong-route delivery of neuraxial medicines (such as bupivacaine) intravenously. 1 ISO (International Organization for Standardization) is the world s largest developer of voluntary International Standards. It has published more than 19,500 International Standards covering 3

4 5. What are the implications of these new standards? Unique connector designs promote patient safety and helps ensure that connectors for unrelated applications are incompatible. This reduces the chances of wrong route injections, infusions and the harm associated with these incidents. Syringes used for intravascular and hypodermic access will no longer be interchangeable with neuraxial syringes. For manufacturers and suppliers this may/ cause temporary inconvenience as procedure packs may be more difficult to customize. Clinicians need to be aware of what extra items ( drop-ins 2 ) they use, as those will need to be ordered specifically: pulling those from intravenous supplies stock will no longer suffice. Pharmacy departments preparing medicines for intrathecal and epidural use (for example, aseptic preparation of intrathecal chemotherapy preparations) will also have to ensure they have appropriate stocks of syringes, syringe caps, filling devices, filters and other equipment necessary to fill and dispense using the new connectors. 6. What connectors are affected by the ISO (NRFit) connector standard? applications involve the use of medical devices to administer medications to and take samples from neuraxial sites (central nervous system including intracranial and spinal canal such as epidural and intrathecal), major peripheral nerve local anaesthetic blockade and continuous wound infiltration. This includes anaesthetic delivery, monitoring cerebrospinal fluid (CSF) pressure, and removing CSF for therapeutic or diagnostic purposes. 7. Which devices are affected by the ISO standard? Neuraxial devices and devices for major regional anesthesia that currently use Luer connectors will, over the next few years, incorporate the connectors. 8. Who developed the proposed new ISO connector design? This new connector design was developed by ISO through the combined global effort of clinicians, regulators, test houses and industry. The ISO connector has undergone a rigorous validation process including computer aided design (CAD) misconnection tests, laboratory leak testing, human factors and usability assessment. 2 Drop in is a phrase used by industry for devices from other suppliers that are added by clinicians to procedure packs to make a complete kit. 4

5 9. Why should we adopt the new connector? The ISO connector provides a simple way to reduce the risk of neuraxial misconnections and improve patient safety. The new connector reduces the chance of an unintentional cross-connection with any other connector intended for non-neuraxial routes. In some countries, the legal systems expect clinical staff to take all reasonable steps to mitigate the risk of cross-connection incidents, and therefore may expect clinical staff to use devices that use these application specific connectors. Non-adoption of the new connectors may expose clinical staff and organizations to legal challenges if further wrong-route incidents take place which could have been prevented by use of ISO compliant devices. 10. What makes the new ISO connector different from the current Luer system? The new ISO connector looks like a Luer connector, but is about 20% smaller and has a unique design that reduces the risk of cross connection with other connectors developed under the same series of standards, especially with Luer connectors. There is one visible difference: slip males will have a collar surrounding the connector. 11. When will the new ISO connector be available? Neuraxial devices with the ISO connector are expected to be available starting in the U.S., Canada and other markets in The ISO connector should be introduced into use with minimal disruption. Timing is subject to change pending regulatory agency clearance and each manufacturer s readiness. Check with your supplier representative for precise timing and device-specific details. 12. How will the new ISO connector be introduced into my healthcare organization? This will vary depending on where you are based. In some countries, it will be under the direction of regulatory authorities and practice experts. In other countries the decision of when to deploy ISO compliant devices may be up to local healthcare organizations or Governments. No matter who is driving the process, healthcare facilities and providers will be able to call upon industry to help them with a careful transition plan to replace Luer devices with the new ISO connector. Although each company may follow their own device and market launch timeline, it is expected that there will be substantial efforts to coordinate the availability of devices in a way that minimizes confusion and logistical problems. To that end, the global industry group has agreed to: Develop and execute a coordinated communications initiative Use a common brand name for the ISO connector NRFit. Use the same time frame to introduce neuraxial devices with the new connector 5

6 13. If we use Neuraxial parts from another manufacturer s set, how will we know the products will work together? As long as the connectors have been produced in compliance with the ISO standard, then it is expected that the devices will connect together effectively and safely. All major neuraxial device manufacturers are expected to comply with the proposed new ISO standards to help ensure neuraxial components fit together as a system. Many compatible devices will be marked with the NRFit label or with the standard number (ISO ). For clinician convenience, some items, such as syringe plungers, may be colored yellow. 14. Is it mandatory to transition to the new ISO connector? This varies by jurisdiction. For example, in California all epidural use must be transitioned by January 1, In the UK, the National Health Service (NHS) has already started planning for the introduction of connectors within 6 months of the California deadline. In Europe and other markets throughout the world, many manufacturers and suppliers are following the subject closely, and plan to adopt the same new global standard connector system. The deployment of devices with the connector may be on different timelines in different global markets, but the goal remains the same to align to a common neuraxial connector across the globe to improve patient safety. 15. When will the neuraxial devices with current connectors be discontinued? Discontinuation of items is at the sole discretion of manufacturers. For precise timing of item discontinuation, contact your supplier representative. The Luer connector for neuraxial devices will be phased out of hospitals on varying timelines. It is important to understand that some devices, such as spinal needles, are presently used for non-neuraxial applications, such as amniocentesis and joint injections. The use of long needles with a Luer connector will still be required after the change to connectors, and some manufacturers have declared their intent to market such devices to meet clinical needs. You should start contacting the suppliers of the needles you presently use and ask them what plans they have for long needles with Luer connectors in the future. If this does not happen, then there is a risk that many common clinical procedures will find themselves in difficulty after the withdrawal of Luer-based spinal needles from the healthcare setting. 16. Will there be new item numbers or SKUs for the new sets? Introduction of new items and related issues such as new item numbers are at the sole discretion of manufacturers. For precise answers relative to new item introductions, contact your supplier representative. In the UK, clinical incidents have already arisen over confusion between proprietary neuraxial connector devices and standard Luer devices, resulting in delays to treatments. It is anticipated that many manufacturers will use product codes that allow individuals to distinguish easily between Luer and ISO devices to avoid such incidents. In countries where proprietary non-luer connectors are already in use the codes will also be different, but there will be need for additional vigilance in these settings. 6

7 17. If applicable, when will the new item numbers be available and how will we know when to order the new item numbers (SKUs)? Introduction of new items and related issues, such as new item numbers, are at the sole discretion of manufacturers. For precise answers relative to new item introductions, contact your supplier representative. 18. Will there be a price increase? Pricing is at the sole discretion of device manufacturers. 19. Will there be a standard color for the connector? Color-coding is not included in the ISO series of standards. The standards will only address the shape and size of the new connectors. These engineering controls make it unlikely that two unintended connectors will fit together. While you might see a consistent color used for devices with neuraxial connectors, it is not a requirement. There is, however, a trend in parts of the world to use the color yellow to indicate neuraxial routes. This feature would be provided for convenience, not safety. 20. What is the role of StayConnected? StayConnected is the implementation branch of the Global Enteral Device Supplier Association (GEDSA) which is a federally tax exempt non-profit trade association StayConnected was established in part to help introduce the new ISO standard connectors and facilitate adoption of the new connectors with the healthcare community. GEDSA, which is composed of leading manufacturers and distributors of medical devices, is united by a shared desire to increase patient safety and optimal delivery of neuraxial treatments and procedures. GEDSA speaks with a unified voice to communicate with government agencies, professional associations, healthcare institutions and member suppliers regarding issues that face device manufacturers, suppliers and distributors. GEDSA will lead StayConnected, a joint communication initiative on behalf of the industry to ensure consistency and avoid any confusion as new, safer connectors are introduced in market. 21. Does this new system require that devices using the Luer connector become obsolete? The Luer connector will still be used for intravascular and hypodermic access and now has its own standard in the ISO series ISO It is, however, expected that availability of neuraxial devices using Luer connectors will decline rapidly because of the significant patient safety benefits associated with a connector which will not cross-connect with Luer. One of the most effective ways to comprehensively reduce the risk of misconnections and enhance patient safety is to ensure that connectors of different delivery systems (i.e., neuraxial and intravascular) are not compatible. 22. Will there be adapters for different kinds of syringes? There will be no adapters for ISO syringes. Syringes will be supplied with the application specific connector. 7

8 692 N. High St. Suite 304 Columbus, OH USA gedsa.org Prepared by GEDSA 8

This document is a preview generated by EVS

This document is a preview generated by EVS INTERNATIONAL STANDARD ISO 80369-7 First edition 2016-10-15 Corrected version 2016-12-01 Small-bore connectors for liquids and gases in healthcare applications Part 7: Connectors for intravascular or hypodermic

More information

To: Commissioners of Prefectural/Cities with Established Health Centers/Special District Health Department (Bureau)

To: Commissioners of Prefectural/Cities with Established Health Centers/Special District Health Department (Bureau) HPB/GAD Notification No. 1227-1 PSEHB/PED Notification No. 1227-1 PSEHB/MDED Notification No. 1227-1 PSEHB/PSD Notification No. 1227-1 December 27, 2017 To: Commissioners of Prefectural/Cities with Established

More information

ICAHN Targeted Focus Area: Medication Devices and Technology

ICAHN Targeted Focus Area: Medication Devices and Technology ICAHN Targeted Focus Area: Medication Devices and Technology Matthew Fricker, RPh, MS, FASHP Program Director, ISMP Rebecca Lamis, PharmD, FISMP Medication Safety Analyst, ISMP April 24, 2014 1 Objectives

More information

Your Complete Outsourcing Partner EXPERTISE TO TURN YOUR IDEAS INTO REALITY

Your Complete Outsourcing Partner EXPERTISE TO TURN YOUR IDEAS INTO REALITY Your Complete Outsourcing Partner EXPERTISE TO TURN YOUR IDEAS INTO REALITY The difference between a vendor and a partner THERE ARE OEM SUPPLIERS. THEN THERE S B. BRAUN S OEM DIVISION. We set ourselves

More information

Advancing the Delivery of Home Infusion Therapy curlinpump.com

Advancing the Delivery of Home Infusion Therapy curlinpump.com Advancing the Delivery of Home Infusion Therapy curlinpump.com Innovative, multi-therapy pump designed for more precise and efficient infusions Home healthcare and drug advancements place new demands on

More information

with Nemera s extensive experience in developing and manufacturing parenteral drug delivery devices

with Nemera s extensive experience in developing and manufacturing parenteral drug delivery devices Co-Development INJECTING NEW IDEAS Empower patients through good design Parenteral administration of a drug exposes users (patients and healthcare professionals) to numerous hazards. In designing a medical

More information

The Device Side of Combination Products

The Device Side of Combination Products The Device Side of Combination Products Technical and Regulatory Challenges in Life Cycle Management Bob Laughner Associate Director, Combination Products 04 May 2016 What are combination products? Combination

More information

DIFFERENTIATION WITHOUT DISRUPTION

DIFFERENTIATION WITHOUT DISRUPTION DIFFERENTIATION WITHOUT DISRUPTION In this article, Alan Shortall, Chief Executive Officer, Unilife Corporation, describes a new paradigm now driving the pharmaceutical market for advanced drug delivery

More information

Drug Products, Labeling, and Packaging

Drug Products, Labeling, and Packaging 442 Pharmaceutical Industry: Drug Products, Labeling, and Packaging Positions Drug Products, Labeling, and Packaging Ready-to-Administer Packaging for Hazardous Drug Products Intended for Home Use (1711)

More information

ChemoClave System Oncology Kits and Multi-Packs

ChemoClave System Oncology Kits and Multi-Packs A complete line of pre-packed oncology solutions that are safe and easy to use during the entire hazardous drug handling process. ChemoClave System Oncology Kits and Multi-Packs > > Save time by eliminating

More information

Contents. Introduction

Contents. Introduction Introduction Contents Medi-Waste is a specialist company that evolved in 1987 providing the collection, transport and disposal of biomedical waste, (including off spec and out of date pharmaceuticals,

More information

TECHNICAL DATA SHEET BD Emerald Syringe with and without needle Sterile, Single Use, Latex free

TECHNICAL DATA SHEET BD Emerald Syringe with and without needle Sterile, Single Use, Latex free BD Sàrl TECHNICAL DATA SHEET BD Emerald Syringe with and without needle Sterile, Single Use, Latex free 1.0 General Information 1.1 General The BD Emerald syringe is a medical single use product for injection

More information

Value Plastics, inc. SPECIALISTS IN FLUID CONNECTIONS

Value Plastics, inc. SPECIALISTS IN FLUID CONNECTIONS Value Plastics, inc. SERVICE QUALITY DELIVERY PROVEN PRECISION INNOVATION TRUSTED LEADERSHIP DIRECT SALES CUSTOM PARTS QUICK CONNECT FITTINGS SANITARY FITTINGS LUERS TUBE-TO-TUBE BLOOD PRESSURE THREADED

More information

Venue. Ultrasound for the critical moment. Simple. Fast. Precise. gehealthcare.com

Venue. Ultrasound for the critical moment. Simple. Fast. Precise. gehealthcare.com Venue Ultrasound for the critical moment Simple. Fast. Precise. gehealthcare.com In the critical moment, every second matters. Seamless flat display Make cleaning a breeze. Convenient button probe Control

More information

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Reportable Events During Pre-Market Clinical Investigations

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Reportable Events During Pre-Market Clinical Investigations SG2&5(PD1)N5R10 PROPOSED DOCUMENT Global Harmonization Task Force Title: Reportable Events During Pre-Market Clinical Investigations Authoring Group: Study Groups 2 and 5 Date: 7 June 2011 CONTENTS Reportable

More information

Streamlined Blow-Fill-Seal Insertion Technology Increases Flexibility and Safety in Aseptic Packaging of Pharmaceutical Liquids

Streamlined Blow-Fill-Seal Insertion Technology Increases Flexibility and Safety in Aseptic Packaging of Pharmaceutical Liquids Streamlined Blow-Fill-Seal Insertion Technology Increases Flexibility and Safety in Aseptic Packaging of Pharmaceutical Liquids Isolators adapted specifically for blow-fill-seal insertion applications

More information

CASE STUDY Recalled Blood Monitoring Medical Device

CASE STUDY Recalled Blood Monitoring Medical Device CASE STUDY Recalled Blood Monitoring Medical Device In-home medical devices are among the most complicated products to recall because unlike, say, food or consumer products abruptly pulling a product off

More information

SECTION: PATIENT CARE Number:

SECTION: PATIENT CARE Number: SUBJECT: Safe Handling of Hazardous Drugs Page: 1 of 10 INTRODUCTION Purpose: This policy has been developed to promote safe work practices for all employees who prepare or administer hazardous drugs or

More information

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB Translated English of Chinese Standard: GB18671-2009 www.chinesestandard.net Sales@ChineseStandard.net ICS 11.040.20 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB C 31 Replacing GB 18671-2002

More information

Part 4: Prefilled syringes

Part 4: Prefilled syringes INTERNATIONAL STANDARD ISO 11040-4 Third edition 2015-04-01 Prefilled syringes Part 4: Glass barrels for injectables and sterilized subassembled syringes ready for filling Seringues préremplies Partie

More information

How are GS1 and IHTSDO standards working together?

How are GS1 and IHTSDO standards working together? How are GS1 and IHTSDO standards working together? Mark Brommeyer Manager Supply Chain Global GS1 Healthcare Conference, Buenos Aires 25 April 2013 0 National E-Health Transition Authority Agenda 1. AMT

More information

New product code functionality starting Multiple product codes for each article number

New product code functionality starting Multiple product codes for each article number To our submitters of medicines New product code functionality starting 1.1.2018 Multiple product codes can be added to each article number in VareWeb Product codes for inner packs can be registered in

More information

FDA s Bar Code Label Requirements for Human Drug Products. General Questions Related to Drugs and Biologics

FDA s Bar Code Label Requirements for Human Drug Products. General Questions Related to Drugs and Biologics FDA s Bar Code Label Requirements for Human Drug Products General Questions Related to Drugs and Biologics 1. Which medical products should carry a bar code? For example, should all prescription and over-the-counter

More information

BRITISH GENERIC MANUFACTURERS ASSOCIATION

BRITISH GENERIC MANUFACTURERS ASSOCIATION BRITISH GENERIC MANUFACTURERS ASSOCIATION Response by the British Generic Manufacturers Association (BGMA) to the Department of Health Consultation on Amendments to the Statutory Scheme to Control the

More information

Teleflex Incorporated (NYSE: TFX) Investor Presentation

Teleflex Incorporated (NYSE: TFX) Investor Presentation Teleflex Incorporated (NYSE: TFX) Investor Presentation Important Information 2 Forward Looking Statements This presentation and our discussion contain forward-looking information and statements, which

More information

510(k) Summary. 510(k) Number: K Summary Prepared: August 31, 2017

510(k) Summary. 510(k) Number: K Summary Prepared: August 31, 2017 510(k) Summary 510(k) Number: K162613 Summary Prepared: August 31, 2017 Submitter: Dr. Fred Ma Repro Med System, Inc., D/B/A RMS Medical Products 24 Carpenter Road, Chester, NY 10918 Tel: 845-469-2042

More information

FDA PLANS TO REGULATE TESTS AS DEVICES. August 2010 SPECIAL REPRINT. By Ellen Flannery and Scott Danzis

FDA PLANS TO REGULATE TESTS AS DEVICES. August 2010 SPECIAL REPRINT. By Ellen Flannery and Scott Danzis August 2010 SPECIAL REPRINT FDA PLANS TO REGULATE LABORATOR ORY DEVELOPED TESTS AS DEVICES By Ellen Flannery and Scott Danzis Reproduced with the kind permission of Global Regulatory Press from the Journal

More information

Automated compounding for intravenous chemotherapy

Automated compounding for intravenous chemotherapy Automated compounding for intravenous chemotherapy Not valid for printing! Low resolution PDF file. For high resolution files, please contact Communication & Image Dept. The correct preparation and administration

More information

March 4, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

March 4, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852 March 4, 2014 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA 2013-N-1523: Request for Nominations: Drug Products that

More information

Solutions for All Your Aseptic Parenteral Drug Formulation/Filling Needs. BUBBLE-FREE FILLING : A New Option in Prefilled Syringe Filling

Solutions for All Your Aseptic Parenteral Drug Formulation/Filling Needs. BUBBLE-FREE FILLING : A New Option in Prefilled Syringe Filling WHITEPAPER Hyaluron Contract Manufacturing Solutions for All Your Aseptic Parenteral Drug Formulation/Filling Needs BUBBLE-FREE FILLING : A New Option in Prefilled Syringe Filling Introduction The advent

More information

Safe Medication. Disposable Syringes

Safe Medication. Disposable Syringes Safe Medication Disposable Syringes Disposable Syringes Safe Medication Safety, reliability, and accuracy down to the smallest detail as with all other CODAN products, this commitment also holds true for

More information

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017 Supply of aseptically - prepared doses of IMPs across legal boundaries Edition 1 December 2017 Endorsed and supported by: NHS Pharmaceutical Quality Assurance Committee 2017 with National Pharmacy Clinical

More information

CADTH COMMON DRUG REVIEW. Procedure for the CADTH Common Drug Review

CADTH COMMON DRUG REVIEW. Procedure for the CADTH Common Drug Review CADTH COMMON DRUG REVIEW Procedure for the CADTH Common Drug Review AUGUST 2014 RECORD OF UPDATES TO THE PROCEDURE FOR THE CADTH COMMON DRUG REVIEW Update Original June 2003 1 January 2005 2 July 2005

More information

Easy EHR Issue Reporting Challenge. June 7, 2018

Easy EHR Issue Reporting Challenge. June 7, 2018 Easy EHR Issue Reporting Challenge June 7, 2018 On Today s Call Challenge Team: Adam Wong, Office of the National Coordinator for Health IT Marcy Opstal, Office of the National Coordinator for Health IT

More information

CANADA (HEALTH CANADA)

CANADA (HEALTH CANADA) 1 GMP GAZETTE TM March 2015 HPFBI CANADA (HEALTH CANADA) Notice, Re: Regulatory Decision Summaries and Submissions Under Review Who s affected? Manufacturers of prescription drugs (pharmaceuticals and

More information

SAN TM PRODUCT FAMILY SAFE AUTO-NEEDLES TM. Better injectors. Better compliance. Better care.

SAN TM PRODUCT FAMILY SAFE AUTO-NEEDLES TM. Better injectors. Better compliance. Better care. SAFE AUTO-NEEDLES TM SAN TM PRODUCT FAMILY Better injectors. Better compliance. Better care. Addressing patient-centered challenges in injectable drug delivery Compatible with: Prefilled syringes (luer

More information

Guideline on the label design for Injections (Draft for Comments)

Guideline on the label design for Injections (Draft for Comments) Guideline on the label design for Injections (Draft for Comments) 2018.3 Content Foreword... 3 1. Scope... 4 2. Terms and definitions... 4 3. Basic requirements for labels... 4 4. Design principles of

More information

Cardinal Health overview and strategic priorities

Cardinal Health overview and strategic priorities Cardinal Health overview and strategic priorities Steve Inacker President, Channel Management Medical Segment Copyright 2011, Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. Cardinal

More information

This document is a preview generated by EVS

This document is a preview generated by EVS INTERNATIONAL STANDARD ISO 7864 Fourth edition 2016-08-01 Sterile hypodermic needles for single use Requirements and test methods Aiguilles hypodermiques stériles, non réutilisables Exigences et méthodes

More information

Leading Pharmacy Benefits Manager (PBM) Implements ProcurePort esourcing to Efficiently Source Prescription Drugs

Leading Pharmacy Benefits Manager (PBM) Implements ProcurePort esourcing to Efficiently Source Prescription Drugs Leading Pharmacy Benefits Manager (PBM) Implements ProcurePort esourcing to Efficiently Source Prescription Drugs Company Profile Leading pharmacy benefits manager (PBM) that partners with leading health

More information

Manufacturers. Factsheet for. of Medical Devices. Medical Devices Regulation (MDR) background. Act now to be ready on time!

Manufacturers. Factsheet for. of Medical Devices. Medical Devices Regulation (MDR) background. Act now to be ready on time! Ref. Ares(2018)3873669-20/07/2018 Factsheet for Manufacturers of Medical Devices This Factsheet is aimed at manufacturers of medical devices. For a general overview of the impact of the In-Vitro Medical

More information

Technologies to Prevent Medication Errors in Hospitals

Technologies to Prevent Medication Errors in Hospitals Technologies to Prevent Medication Errors in Hospitals CSHP Professional Practice Conference February 2, 2004 David U President and CEO, ISMP Canada ISMP CANADA Vision:! ISMP Canada is an independent Canadian

More information

-- Study achieved statistical significance on all primary and secondary biological endpoints --

-- Study achieved statistical significance on all primary and secondary biological endpoints -- Sarepta Therapeutics Announces Positive Results in Its Study Evaluating Gene Expression, Dystrophin Production, and Dystrophin Localization in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to

More information

Management. National Standards Authority of Ireland

Management. National Standards Authority of Ireland Medical Equipment Quality Management NSAI: Role and Structure of Standards Brian Cunningham 2009-03-26 National Standards Authority of Ireland Statutory body Formed in 1947 as IIRS 1996 NSAI Act Functions

More information

ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY

ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY The delivery of high volumes of biologics outside of the clinical setting remains a key challenge in the industry. Here, John

More information

S P O N S O R E D B Y

S P O N S O R E D B Y S P O N S O R E D B Y The Value of Visibility Data Seeing and Benefiting from Data after its Capture Example: Preparing for Serialization and Pedigree within the U.S. Pharmaceutical Supply Chain Agenda

More information

THE SARSTEDT GROUP. Your Partner in Medicine. and Science Worldwide

THE SARSTEDT GROUP. Your Partner in Medicine. and Science Worldwide THE SARSTEDT GROUP Your Partner in Medicine and Science Worldwide 1 THE SARSTEDT GROUP WORLDWIDE Your Partner in Medicine and Science Worldwide The SARSTEDT Group, with headquarters in Nümbrecht, Germany,

More information

Public Consultation on Annual Review and Proposal for Fees For Financial Year Medical Devices

Public Consultation on Annual Review and Proposal for Fees For Financial Year Medical Devices Public Consultation on Annual Review and Proposal for Fees For Financial Year 2018 Medical Devices 8th May 2018 CONTENTS 1 INTRODUCTION 3 2 REVIEW OF THE 2017 FEES 3 2.1 The 2017 fees 3 2.2 The 2018 fees

More information

A New Era of Clinical Diagnostics: How the Business Model is Changing.

A New Era of Clinical Diagnostics: How the Business Model is Changing. A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September

More information

Environmental Services Conference

Environmental Services Conference Sharps Compliance Corp. NASDAQ: SMED Credit Suisse Industrial and Environmental Services Conference May 24, 2011 Diana P. Diaz Vice President and Chief Financial Officer 1 Safe Harbor Statement These slides

More information

NEW EU Regulations and the EU UDI system

NEW EU Regulations and the EU UDI system NEW EU Regulations and the EU UDI system 24 October 2017, Brussels Géraldine Lissalde-Bonnet Director Public Policy, GS1 Global Office Disclaimer Neither GS1 nor its member organizations nor their staffs

More information

Consulted With; Post/Committee/Group Date Haematology Dr Shereen Elshazly (Lead for Anticoagulation) January 2016 Department of Anaesthesia

Consulted With; Post/Committee/Group Date Haematology Dr Shereen Elshazly (Lead for Anticoagulation) January 2016 Department of Anaesthesia Peri-procedural anticoagulation in Adult patients taking Warfarin and novel oral anti-coagulants (NOACS) Clinical Guideline Register No: 16005 Status: Public Developed in response to: Contributes to CQC

More information

Scan4Safety. Implications on Hospital Pharmacy and effect on delivery of healthcare November 2017

Scan4Safety. Implications on Hospital Pharmacy and effect on delivery of healthcare November 2017 Scan4Safety Implications on Hospital Pharmacy and effect on delivery of healthcare November 2017 Evolution NHS eprocurement strategy GS1 and PEPPOL Scan4Safety Audience Patients Trusts Suppliers Technology

More information

Product Catalog (Canada) Conventional Needles I.V. Catheters Micro-Collection Products Safety Products Winged Infusion Sets

Product Catalog (Canada) Conventional Needles I.V. Catheters Micro-Collection Products Safety Products Winged Infusion Sets Product Catalog (Canada) Conventional Needles I.V. Catheters Micro-Collection Products Safety Products Winged Infusion Sets Table of Contents Hypodermics SurGuard 3 Safety Hypodermic Needle 3-4 Terumo

More information

Compounding Questions and Answers

Compounding Questions and Answers Compounding Questions and Answers JANUARY 10, 2011 1. Question: What is a reliable supplier? Answer: Some examples of reliable suppliers are FDA licensed manufacturers, CA Department of Public Health Food

More information

BUSINESS OBJECTIVES AND FUTURE PLANS

BUSINESS OBJECTIVES AND FUTURE PLANS BUSINESS OBJECTIVES AND STRATEGIES Our objectives are to consolidate and strengthen our position to become one of the leading distributors of pharmaceutical products in Zhejiang province. To further develop

More information

Business Continuity Management Policy

Business Continuity Management Policy Business Continuity Management Policy Version FINAL 1.0 Ratified by Dudley CCG Audit Committee Date ratified 17/03/16 Name of originator(s) / author(s) David Morris, Midlands and Lancashire CSU/ Sue Johnson,

More information

MEDICAL WASTE MANAGEMENT STUDY NOTES

MEDICAL WASTE MANAGEMENT STUDY NOTES MEDICAL WASTE MANAGEMENT STUDY NOTES UNIT 1 INTRODUCTION Hospital and other health care establishment has a duty of care for the environment and for public health and have particular responsibility in

More information

Anhydrous Ammonia Code of Practice Frequently Asked Questions

Anhydrous Ammonia Code of Practice Frequently Asked Questions Anhydrous Ammonia Code of Practice Frequently Asked Questions 1. I have an audit scheduled this fall (between July 1 and December 31, 2016). Will I be audited to the revised January 2017 Ammonia Code?

More information

Testimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC

Testimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC Testimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC U.S. House of Representatives Energy and Commerce Committee Subcommittee on Health Subcommittee January 30, 2018

More information

This document is a preview generated by EVS

This document is a preview generated by EVS INTERNATIONAL STANDARD ISO 5361 Third edition 2016-09-01 Anaesthetic and respiratory equipment Tracheal tubes and connectors Matériel d anesthésie et de réanimation respiratoire Sondes trachéales et raccords

More information

Supply Chain Congress 21 August 2013 Megan Main, Chief Executive

Supply Chain Congress 21 August 2013 Megan Main, Chief Executive Reforming the health supply chain down under Supply Chain Congress 21 August 2013 Megan Main, Chief Executive Health Purchasing Victoria (HPV) 1. HPV overview 2. Becoming more strategic 3. Global trends

More information

USP800: A quick summary and disposal. Brenda Denson, Pharm.D.

USP800: A quick summary and disposal. Brenda Denson, Pharm.D. USP800: A quick summary and disposal Brenda Denson, Pharm.D. Objectives Review current USP800 guidelines on destruction of hazardous medications. Illustrate how a local pharmacy demonstrates compliance

More information

Infusion management. Complete administration of the medication without rest volumes

Infusion management. Complete administration of the medication without rest volumes Infusion management Complete administration of the medication without rest volumes Drip SWAN and CODAN Guard Complete administration Do you want your patient to receive the whole medication and at the

More information

Re: SUPPLY DISRUPTION - Baxter Colleague pump compatible IV administration sets

Re: SUPPLY DISRUPTION - Baxter Colleague pump compatible IV administration sets For the Attention of the Medical Director URGENT FOR ACTION 10 April 2015 Re: SUPPLY DISRUPTION - Baxter Colleague pump compatible IV administration sets Baxter Healthcare has notified us that they are

More information

GS1 Guide on Unique Device Identification (UDI) implementation

GS1 Guide on Unique Device Identification (UDI) implementation GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.

More information

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no. +220 4380632 GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS Document no: MCA/IMPG/2017/1

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL MEDICAL DEVICES and IVDs ESSENTIAL PRINCIPLES of SAFETY & PERFORMANCE This guideline is intended to provide recommendations to applicants wishing to sell medical devices and IVDs

More information

THE PARTNER FOR INNOVATIVE SOLUTIONS

THE PARTNER FOR INNOVATIVE SOLUTIONS 04 THE PARTNER FOR INNOVATIVE SOLUTIONS THE COMPANY WHO ARE WE? Over the past 30 years, ROVIPHARM has become the specialist manufacturer of medical and dosing devices for the pharmaceutical and healthcare

More information

VALUE WITHOUT COMPARISON DIAGNOSTIC PROCEDURE TRAYS. Quality Without Compromise VALUE WITHOUT COMPARISON

VALUE WITHOUT COMPARISON DIAGNOSTIC PROCEDURE TRAYS. Quality Without Compromise VALUE WITHOUT COMPARISON Quality Without Compromise Value Without Comparison VALUE WITHOUT COMPARISON Quality Without Compromise QUALITY WITHOUT COMPROMISE VALUE WITHOUT COMPARISON VALUE WITHOUT COMPARISON DIAGNOSTIC PROCEDURE

More information

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT

More information

UPS Healthcare Supply Chain Vital Signs

UPS Healthcare Supply Chain Vital Signs UPS Study Executive September 2017 START 2017 UPS Survey 2017 United Parcel Service of America, Inc. 1 An industry growing more complex: managing competition, compliance and costs Pharmacies are grappling

More information

Global Medical Device Nomenclature (GMDN)

Global Medical Device Nomenclature (GMDN) Global Medical Device Nomenclature (GMDN) GMDN A Requirement for UDI Edward Glenn, Term Developer - GMDN Agency What we will be discussing Why is the GMDN needed GMDN data structure How to find GMDN terms

More information

Cancer Vanguard. Biosimilars Trust Policy Template

Cancer Vanguard. Biosimilars Trust Policy Template Cancer Vanguard Biosimilars Trust Policy Template Aim of this document: The document provides generic guidance and outline for the development of local trust policies in relation to the adoption of biosimilars

More information

PUTTING PATIENTS FIRST: INNOVATING DRUG CONTAINMENT AND DELIVERY

PUTTING PATIENTS FIRST: INNOVATING DRUG CONTAINMENT AND DELIVERY PUTTING PATIENTS FIRST: INNOVATING DRUG CONTAINMENT AND DELIVERY Innovations in self-administered drug delivery systems are supporting care for a variety of medical conditions transitioning out of hospitals

More information

Anaesthetic and respiratory equipment Tracheostomy tubes and connectors

Anaesthetic and respiratory equipment Tracheostomy tubes and connectors INTERNATIONAL STANDARD ISO 5366 First edition 2016-10-01 Anaesthetic and respiratory equipment Tracheostomy tubes and connectors Matériel d anesthésie et de réanimation respiratoire Raccords et tubes de

More information

GUIDE HEA

GUIDE HEA Companies are often overwhelmed by the field of digital health. From digital and med device companies to biotechnology and pharmaceutical companies, there is a struggle to cut through the noise of numerous

More information

Medicines Barcoding and Serialization Guideline. National Health Regulatory Authority (NHRA) Kingdom of Bahrain

Medicines Barcoding and Serialization Guideline. National Health Regulatory Authority (NHRA) Kingdom of Bahrain edicines Barcoding and Serialization Guideline National Health Regulatory Authority (NHRA) Kingdom of Bahrain August 2018 Version 1.0 Chief of Pharmaceutical Product Regulation: Dr / Roaya Al Abbasi Date:

More information

The Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time

The Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time The Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time Clinical Trial Supply Southeast 2015 July 15 th July 16 th RTP, North Carolina Presenters: Eva Allen Heather Phillips

More information

The future of biologics: reverse engineering for successful product supply

The future of biologics: reverse engineering for successful product supply The future of biologics: reverse engineering for successful product supply CORNELL STAMORAN VP, STRATEGY & CORPORATE DEV T. 03.10.11 Catalent s biologics presence Advanced GPEx cell line engineering technology

More information

34 th Annual J.P. Morgan Healthcare Conference

34 th Annual J.P. Morgan Healthcare Conference 34 th Annual J.P. Morgan Healthcare Conference Vincent A. Forlenza Chairman, Chief Executive Officer and President January 13, 2016 Forward-Looking Statements These materials include forward-looking statements

More information

U.S. Hospitals Study Executive Summary

U.S. Hospitals Study Executive Summary UPS Healthcare Study Executive September 2017 START 2017 Survey 2017 United Parcel Service of America, Inc. 1 An industry facing disruptive change: managing consumerization, clinical outcomes and costs

More information

REQUEST FOR PROPOSALS SUPPLY OF NEEDLES AND SYRINGES (INCLUDING SOME SPECIALTY PRODUCTS)

REQUEST FOR PROPOSALS SUPPLY OF NEEDLES AND SYRINGES (INCLUDING SOME SPECIALTY PRODUCTS) 03 November 2017 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF NEEDLES AND SYRINGES (INCLUDING SOME SPECIALTY PRODUCTS) PHARMAC invites proposals for the supply of Needles and Syringes in New Zealand District

More information

Purchasing for Safety Policy for Pharmaceuticals January Page 1 of 8 (Purchasing for Safety Policy for Pharmaceuticals)

Purchasing for Safety Policy for Pharmaceuticals January Page 1 of 8 (Purchasing for Safety Policy for Pharmaceuticals) Purchasing for Safety Policy for s January 2010 Page 1 of 8 (Purchasing for Safety Policy for s) Policy Title Purchasing for Safety Policy for s Policy Reference Number Acute10/006 Implementation Date

More information

INFLATIONARY INDICES JULY 1, DECEMBER 31, 2012

INFLATIONARY INDICES JULY 1, DECEMBER 31, 2012 INFLATIONARY INDICES JULY 1, 2011 - DECEMBER 31, 2012 AMERINET INFLATIONARY INDICES Amerinet s Customer-Focused Portfolio Get on the fast track to savings. A typical healthcare provider can reduce costs

More information

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil

More information

Manufacturers. Factsheet for. of Medical Devices. Medical Devices Regulation (MDR) background. Act now to be ready on time!

Manufacturers. Factsheet for. of Medical Devices. Medical Devices Regulation (MDR) background. Act now to be ready on time! European Commission Factsheet for Manufacturers of Medical Devices This Factsheet is aimed at manufacturers of medical devices. For a general overview of the impact of the In Vitro Medical Devices Regulation

More information

Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994

Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994 Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994 SUR-G0006-2 27 AUGUST 2010 This guide does not purport to be an interpretation of law and/or

More information

Product Catalog (US) Conventional Needles I.V. Catheters Micro-Collection Products Safety Products Winged Infusion Sets

Product Catalog (US) Conventional Needles I.V. Catheters Micro-Collection Products Safety Products Winged Infusion Sets Product Catalog (US) Conventional Needles I.V. Catheters Micro-Collection Products Safety Products Winged Infusion Sets Table of Contents Hypodermics SurGuard 3 Safety Hypodermic Needle 3-4 Terumo Standard

More information

Guideline for Theraputic Plasma Exchange

Guideline for Theraputic Plasma Exchange Guideline for Theraputic Plasma Exchange Therapeutic plasma exchange (TPE) removes large-molecular-weight substances such as harmful antibodies from the plasma. It is usually carried out using an automated

More information

Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program?

Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program? Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program? Cisco Vicenty Case for Quality Program Manager Center for Devices and Radiological Health U.S. Food and Drug Administration,

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit

More information

P E D A L A P P R O A C H

P E D A L A P P R O A C H PEDAL APPROACH PEDAL APPROACH SET-UP & ACCESS ANGIOGRAPHY INTERVENTION HEMOSTASIS INTEGRATE Merit Medical offers the most comprehensive suite of products for pedal access. From Set Up & Access to Hemostasis,

More information

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices Lisa L. Michels General Counsel & Regulatory Expert Susan J. Schniepp, Distinguished Fellow Regulatory Compliance Associates Inc. U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical

More information

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction As precision

More information

Developing a European First-in-Human Study: Three Key Decisions

Developing a European First-in-Human Study: Three Key Decisions Developing a European First-in-Human Study: Three Key Decisions By Nicole Feist, BA Clinical A key step in the translational medicine benchtop to bedside process model is the move from research and preclinical

More information

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products Purpose This GS1 Healthcare paper has been written to help demonstrate ways in which GS1 bar codes can be used to minimise the need for multiple bar codes to appear on product packaging while still enabling

More information

DRAFTS IN WIDE CIRCULATION DOCUMENT DESPATCH ADVICE MHD 10/ T- 2,3,41,33,43,44,45,46,47,48 10/02/2015 TECHNICAL COMMITTEE: MHD 10

DRAFTS IN WIDE CIRCULATION DOCUMENT DESPATCH ADVICE MHD 10/ T- 2,3,41,33,43,44,45,46,47,48 10/02/2015 TECHNICAL COMMITTEE: MHD 10 DRAFTS IN WIDE CIRCULATION TECHNICAL COMMITTEE: MHD 10 DOCUMENT DESPATCH ADVICE Ref Date MHD 10/ T- 2,3,41,33,43,44,45,46,47,48 10/02/2015 ADDRESSED TO: 1. All members of Medical Laboratory Instruments

More information

Comfort your patient deserves. Strength you demand.

Comfort your patient deserves. Strength you demand. POLYSITE LOW PROFILE HYBRID PORTS Comfort your patient deserves. Strength you demand. We never settle because you never settle. Throughout our 35-year history, clinicians and patients have benefited from

More information

Healthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018

Healthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018 Healthcare Sector - Upcoming legislations - GS1 standards Ann Luyckx Healthcare Manager Phi Data Event 2018 Anti-trust GS1 Belgium & Luxembourg will not enter into any discussion, activity or conduct that

More information